Products for Research Use Only
RegisterLogin

Balstilimab

CAT: 0804-HY-P99457-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99457-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Balstilimab (AGEN2034) is a fully human monoclonal IgG4 antibody against PD-1[1].
CAS Number
2148321-77-9
Product Name Alternative
AGEN2034
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/balstilimab.html
Purity
99.51
Solubility
H2O
Smiles
[Balstilimab]
Molecular Weight
(143.33 kDa)
References & Citations
[1]Drouin E E, et al. AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary human T cell assays and in a non-human primate pharmacodynamic (PD) model. Cancer Research, 2017, 77 (13_Supplement) : 3654-3654.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
E40YR1550Balstilimab
GTR18337854-01Balstilimab Antibody
KPTX250Balstilimab ELISA Kit
DHH02203Research Grade Balstilimab
E55B0452Balstilimab (Reference antibody)
KBI1169KRIBIOLISA™ Balstilimab ELISA
ICH5369-50mgBalstilimab Biosimilar - Research Grade
GTR18780175-01(Balstilimab) Biosimilar Reference Antibody
GTR18697749-01Balstilimab Human Monoclonal Antibody
591686Balstilimab (PDCD1, PD1, CD279)

Popular Products